Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After Coronary Artery Bypass Surgery (original) (raw)
Comparison of Effectiveness of Atorvastatin 10 mg Versus 80 mg in Reducing Major Cardiovascular Events and Repeat Revascularization in Patients With Previous Percutaneous Coronary Intervention (Post Hoc Analysis of the Treating to New Targets [TNT] Study)
Andrei Breazna, David Waters, John Larosa
The American Journal of Cardiology, 2008
View PDFchevron_right
Long-Term Effects on Clinical Outcomes of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation in the Post Coronary Artery Bypass Graft Trial
Fredarick Gobel
2000
View PDFchevron_right
A randomized pilot trial of low-dose combination lipid-lowering therapy following coronary artery bypass grafting
Beverley Hunt, Mahmoud S Barbir
Clinical Cardiology, 1994
View PDFchevron_right
Effect of an Aggressive Lipid-Lowering Strategy on Progression of Atherosclerosis in the Left Main Coronary Artery From Patients in the Post Coronary Artery Bypass Graft Trial
Fredarick Gobel
Circulation, 2001
View PDFchevron_right
Prompt impact of first prospective statin mega-trials on postoperative lipid management of CABG patients: a 20-year follow-up in a single hospital
Ville Hällberg
Lipids in Health and Disease, 2016
View PDFchevron_right
Safety and Efficacy of Atorvastatin-Induced Very Low-Density Lipoprotein Cholesterol Levels in Patients With Coronary Heart Disease (a Post Hoc Analysis of the Treating to New Targets [TNT] Study) † † Conflicts of interest: Dr. LaRosa has served as a consultant to Pfizer, Inc., New York, New York...
ward alger
American Journal of Cardiology, 2007
View PDFchevron_right
Non-High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI)
Bonnie Weiner, Sheryl Kelsey
2010
View PDFchevron_right
The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial
Fredarick Gobel
Atherosclerosis, 1999
View PDFchevron_right
The prognostic role of the low and very low baseline LDL-C level in outcomes of patients with cardiac revascularization; comparative registry-based cohort design
ali sheikhy
Journal of Cardiothoracic Surgery
View PDFchevron_right
Time-varying effect of postoperative cholesterol profile on long-term outcomes of isolated coronary artery bypass graft surgery
sahar samimi
Lipids in Health and Disease
View PDFchevron_right
Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: The need for targeted follow-up
Andrew Owens
Interactive Cardiovascular and Thoracic Surgery, 2008
View PDFchevron_right
Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study
Jean-Charles Fruchart
Diabetes Care, 2006
View PDFchevron_right
Magnitude and Characteristics of Residual Lipid Risk in Patients With a History of Coronary Revascularization: The ICP-Bypass Study
Gustavo Vitale
Revista Española de Cardiología (English Edition), 2011
View PDFchevron_right
Development of a pharmacist-led cholesterol screening and lipid-lowering medication review service in coronary artery bypass graft patients
David Alldred
International Journal of Pharmacy Practice, 2001
View PDFchevron_right
Lipid Management in High Risk Coronary Patients: How Effective are We at Secondary Intervention?
David Hare
Heart, Lung and Circulation, 2012
View PDFchevron_right
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial
Michael Ezekowitz
European Heart Journal, 2005
View PDFchevron_right
The use of cholesterol-lowering medications after coronary revascularization
Paul Brassard
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003
View PDFchevron_right
Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: Results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registry
C. Melloni
American Heart Journal, 2010
View PDFchevron_right
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study
Jean-Charles Fruchart
The Lancet, 2006
View PDFchevron_right
Lipid Control before CABG and Its Association with In-Hospital Mortality
Maryam Mehrpooya
Iranian Red Crescent medical journal, 2011
View PDFchevron_right
The benefit of cholesterol-lowering medications after coronary revascularization: A population study
Paul Brassard
American Heart Journal, 2005
View PDFchevron_right
Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention
Vasilios Athyros
Current Medical Research and Opinion, 2002
View PDFchevron_right
Effects of Reconstituted High-Density Lipoprotein Infusions on Coronary AtherosclerosisA Randomized Controlled Trial
P. Lallier, Réda Ibrahim
JAMA, 2007
View PDFchevron_right
Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial
Michael Domanski
Diabetes, 1999
View PDFchevron_right
LDL-Lowering Independent Effects of Early Pre-Treatment with High-Dose Statins in Patients Undergoing Percutaneous Coronary Interventions
Annunziata Nusca
EUROPEAN JOURNAL OF CARDIOVASCULAR MEDICINE, 2011
View PDFchevron_right
Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes
John Larosa
Diabetes Care, 2006
View PDFchevron_right
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis
Paul Schoenhagen
JAMA: the journal of …, 2004
View PDFchevron_right
Recent Advances in the Management of Coronary Artery Disease: Highlights From the Literature
Harish Ramakrishna
Journal of Cardiothoracic and Vascular Anesthesia, 2009
View PDFchevron_right
Influence of Achieved Low-Density Lipoprotein Cholesterol Level With Atorvastatin Therapy on Stabilization of Coronary Plaques
Yasunori Ueda
Circulation Journal, 2012
View PDFchevron_right
Relation of High-Density Lipoprotein Cholesterol to Mortality After Percutaneous Coronary Interventions In Patients With Low-Density Lipoprotein< 70 Mg/Dl
W. Patsch
… American Journal of …, 2009
View PDFchevron_right
Effect of atorvastatin on highdensity lipoprotein cholesteroland its relationship withcoronary events: a subgroupanalysis of the GREekAtorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
Vasilios Athyros
Current Medical Research and Opinion, 2004
View PDFchevron_right
Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting
Riccardo Sinatra
European Heart Journal, 2013
View PDFchevron_right
Safety of Simvastatin and Goal Attainment for Low-Density Lipoprotein Cholesterol in Sultan Qaboos University Hospital
Hatem Farhan
Oman Medical Journal, 2010
View PDFchevron_right
Dual antiplatelet treatment after coronary artery bypass surgery
Carlos Morales
Journal of cardiothoracic surgery, 2015
View PDFchevron_right